Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Schachter

Showing results (41-50 of 153) with videos related to

Pageof 16
Sort By:
The Israel Medical Association Journal : IMAJ|January 30, 2010
Outcome of thick (> 4 mm) node-negative melanomasDouglas B Zippel, Roni Shapira, Irena Kuchuk, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patientsGuy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, et al.
Oncology Reports|November 21, 2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanomaJair Bar, Rinat Yerushalmi, Roni Shapira-Frummer, et al.
Frontiers in Immunology|July 28, 2020
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against LeukemiaMeir Rozenbaum, Amilia Meir, Yarden Aharony, et al.
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
Melanoma Research|June 24, 2024
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapyNethanel Asher, Neta Bar-Hai, Guy Ben-Betzalel, et al.
Frontiers in Immunology|October 26, 2017
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 SeparationSivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, et al.
Cancers|June 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with ImmunotherapyNeta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, et al.
Frontiers in Oncology|November 24, 2022
Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patientsRonen Stoff, Shirly Grynberg, Nethanel Asher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machineEster Schallmach, Rina Sareli, Michal J Besser, et al.
Pageof 16

Showing results (41-50 of 153) with videos related to

Sort By:
Pageof 16
The Israel Medical Association Journal : IMAJ|January 30, 2010
Outcome of thick (> 4 mm) node-negative melanomasDouglas B Zippel, Roni Shapira, Irena Kuchuk, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
Immunotherapy comes of age in octagenarian and nonagenarian metastatic melanoma patientsGuy Ben-Betzalel, Yael Steinberg-Silman, Ronen Stoff, et al.
Oncology Reports|November 21, 2008
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanomaJair Bar, Rinat Yerushalmi, Roni Shapira-Frummer, et al.
Frontiers in Immunology|July 28, 2020
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against LeukemiaMeir Rozenbaum, Amilia Meir, Yarden Aharony, et al.
Cancers|July 2, 2021
Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical ExperienceNethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, et al.
Melanoma Research|June 24, 2024
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapyNethanel Asher, Neta Bar-Hai, Guy Ben-Betzalel, et al.
Frontiers in Immunology|October 26, 2017
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 SeparationSivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, et al.
Cancers|June 10, 2023
Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with ImmunotherapyNeta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, et al.
Frontiers in Oncology|November 24, 2022
Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patientsRonen Stoff, Shirly Grynberg, Nethanel Asher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2008
Collection of large-scale expanded lymphocyte cultures for adoptive immunotherapy using a COBE Spectra apheresis machineEster Schallmach, Rina Sareli, Michal J Besser, et al.
Pageof 16